<SEC-DOCUMENT>0001493152-21-001165.txt : 20210115
<SEC-HEADER>0001493152-21-001165.hdr.sgml : 20210115
<ACCEPTANCE-DATETIME>20210115162138
ACCESSION NUMBER:		0001493152-21-001165
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200111
FILED AS OF DATE:		20210115
DATE AS OF CHANGE:		20210115

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Puopolo Anthony David II
		CENTRAL INDEX KEY:			0001840846

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39785
		FILM NUMBER:		21532361

	MAIL ADDRESS:	
		STREET 1:		1101 PLANTATION VILLAGE
		CITY:			DORADO
		STATE:			PR
		ZIP:			00646

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONVERSION LABS, INC.
		CENTRAL INDEX KEY:			0000948320
		STANDARD INDUSTRIAL CLASSIFICATION:	SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
		IRS NUMBER:				760238453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(866) 351-5907

	MAIL ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immudyne, Inc.
		DATE OF NAME CHANGE:	20120514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUDYNE INC
		DATE OF NAME CHANGE:	19950720
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-01-11</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000948320</issuerCik>
        <issuerName>CONVERSION LABS, INC.</issuerName>
        <issuerTradingSymbol>CVLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001840846</rptOwnerCik>
            <rptOwnerName>Puopolo Anthony David II</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CONVERSION LABS, INC,</rptOwnerStreet1>
            <rptOwnerStreet2>800 THIRD AVENUE, SUITE 2800</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10022</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Medical Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Options to purchase shares of Common Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, par value $0.001</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>200000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Pursuant to the terms of the employment agreement, by and between Mr. Puoplo and the Issuer, dated January 11, 2021 (the &quot;Effective Date&quot;), Mr. Puopolo was granted stock options to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.48 per share (the &quot;Stock Options&quot;). 5,555 of the Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 35 months following the approval of the Effective Date, with the remaining 5,575 Stock Options scheduled to vest on January 11, 2024.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Anthony Puopolo</signatureName>
        <signatureDate>2021-01-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
